東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Ultrasonic transdermal glucose monitoring and insulin delivery using cymbal transducer arrays.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Ultrasonic transdermal glucose monitoring and insulin delivery using cymbal transducer arrays./
作者:	Park, Eun-Joo.
面頁冊數:	1 online resource (113 pages)
附註:	Source: Dissertations Abstracts International, Volume: 75-04, Section: B.
Contained By:	Dissertations Abstracts International75-04B.
標題:	Biomedical engineering. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3574370click for full text (PQDT)
ISBN:	9781303492938

Ultrasonic transdermal glucose monitoring and insulin delivery using cymbal transducer arrays.
Park, Eun-Joo.

Ultrasonic transdermal glucose monitoring and insulin delivery using cymbal transducer arrays. - 1 online resource (113 pages)

Source: Dissertations Abstracts International, Volume: 75-04, Section: B.

Thesis (Ph.D.)--The Pennsylvania State University, 2010.

Includes bibliographical references

As a practically portable ultrasound system for transdermal drug delivery, cymbal transducer arrays have shown promise in several in vivo experiments using small animals. The goal of this study was to evaluate the potential of the cymbal transducer array as a pre-clinical application for transdermal insulin delivery and glucose sensing. In order to achieve this goal, several aspects have been investigated, such as the feasibility of ultrasonic transdermal insulin delivery and glucose sensing in large animals, and a closed-loop feedback controller for regulating glucose levels. To evaluate further the practicability of the cymbal transducer array as a pre-clinical application, in vivo experiments with transdermal insulin delivery were performed in large pigs (~ 200 lbs). The results of the ultrasound exposure group indicate that the glucose level decreased to -74 ± 5 mg/dl at 60 minutes and continued to decrease to -91 ± 9 mg/dl at 90 minutes. In addition to the insulin delivery, the cymbal transducer array has been used in determining the glucose concentration of interstitial fluid. From the perspective of application in humans, the in vivo studies using large pigs were designed to determine the feasibility of the cymbal transducer array in ultrasonic transdermal glucose sensing. After 5 minutes of ultrasound exposure at Isptp = 100 mW/cm2, the glucose levels determined by the ultrasound system and glucose meter were 127 ± 16 mg/dl and 131 ± 5 mg/dl, respectively. Based on the results of transdermal insulin delivery and glucose sensing in large pigs, the ultrasound systems for both applications were combined using a closed-loop feedback controller. Four in vivo experiments were designed with large pigs to demonstrate the feasibility of the combined ultrasound system in noninvasive glucose control. Based on the glucose level measured by ultrasound and biosensors at 20-minute intervals, the ultrasound system of insulin delivery was shown to regulate the glucose level. During the 120-minute experiments, glucose levels were controlled in the range of 104-137 mg/dl as determined by the ultrasound system. Through the in vivo experiments of transdermal insulin delivery and glucose, the ultrasound system using the cymbal transducer array has shown the positive potential of a practically portable device for a clinical application of diabetes care.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9781303492938Subjects--Topical Terms:

535387
Biomedical engineering.
Subjects--Index Terms:

Cymbal transducer arraysIndex Terms--Genre/Form:

542853
Electronic books.

Ultrasonic transdermal glucose monitoring and insulin delivery using cymbal transducer arrays.
LDR:03842nmm a2200397K 4500 001 2358972
005 20230830051534.5
006 m o d
007 cr mn ---uuuuu
008 241011s2010 xx obm 000 0 eng d
020 $a 9781303492938
035 $a (MiAaPQ)AAI3574370
035 $a AAI3574370
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Park, Eun-Joo. $3 3699519
245 1 0 $a Ultrasonic transdermal glucose monitoring and insulin delivery using cymbal transducer arrays.
264 0 $c 2010
300 $a 1 online resource (113 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 75-04, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Smith, Nadine Barrie.
502 $a Thesis (Ph.D.)--The Pennsylvania State University, 2010.
504 $a Includes bibliographical references
520 $a As a practically portable ultrasound system for transdermal drug delivery, cymbal transducer arrays have shown promise in several in vivo experiments using small animals. The goal of this study was to evaluate the potential of the cymbal transducer array as a pre-clinical application for transdermal insulin delivery and glucose sensing. In order to achieve this goal, several aspects have been investigated, such as the feasibility of ultrasonic transdermal insulin delivery and glucose sensing in large animals, and a closed-loop feedback controller for regulating glucose levels. To evaluate further the practicability of the cymbal transducer array as a pre-clinical application, in vivo experiments with transdermal insulin delivery were performed in large pigs (~ 200 lbs). The results of the ultrasound exposure group indicate that the glucose level decreased to -74 ± 5 mg/dl at 60 minutes and continued to decrease to -91 ± 9 mg/dl at 90 minutes. In addition to the insulin delivery, the cymbal transducer array has been used in determining the glucose concentration of interstitial fluid. From the perspective of application in humans, the in vivo studies using large pigs were designed to determine the feasibility of the cymbal transducer array in ultrasonic transdermal glucose sensing. After 5 minutes of ultrasound exposure at Isptp = 100 mW/cm2, the glucose levels determined by the ultrasound system and glucose meter were 127 ± 16 mg/dl and 131 ± 5 mg/dl, respectively. Based on the results of transdermal insulin delivery and glucose sensing in large pigs, the ultrasound systems for both applications were combined using a closed-loop feedback controller. Four in vivo experiments were designed with large pigs to demonstrate the feasibility of the combined ultrasound system in noninvasive glucose control. Based on the glucose level measured by ultrasound and biosensors at 20-minute intervals, the ultrasound system of insulin delivery was shown to regulate the glucose level. During the 120-minute experiments, glucose levels were controlled in the range of 104-137 mg/dl as determined by the ultrasound system. Through the in vivo experiments of transdermal insulin delivery and glucose, the ultrasound system using the cymbal transducer array has shown the positive potential of a practically portable device for a clinical application of diabetes care.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Biomedical engineering. $3 535387
650 4 $a Acoustics. $3 879105
650 4 $a Pharmaceutical sciences. $3 3173021
653 $a Cymbal transducer arrays
653 $a Insulin delivery
653 $a Transdermal drug delivery
653 $a Transdermal glucose monitoring
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0541
690 $a 0572
690 $a 0986
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a The Pennsylvania State University. $b Bioengineering. $3 3699520
773 0 $t Dissertations Abstracts International $g 75-04B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3574370 $z click for full text (PQDT)